United States · FDA National Drug Code directory
cholestyramine powder for suspension
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67877-298_a5b0d23a-e47d-491f-9602-a7836b97b13c
- Product NDC
- 67877-298
- Form
- POWDER, FOR SUSPENSION
- Composition / generic term
- cholestyramine powder for suspension
- Labeler
- Ascend Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20211020
- Source listing expiry
- 20271231
Source-listed ingredients
- CHOLESTYRAMINE — 4 g/8.78g
These values do not establish equivalence or a dose recommendation.
Packages
- 368.76 g in 1 JAR (67877-298-37) · 67877-298-37
- 60 POUCH in 1 CARTON (67877-298-60) / 8.78 g in 1 POUCH (67877-298-09) · 67877-298-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →